Group 1 - The company held its 19th meeting of the 11th Board of Directors on February 5, 2026, with 7 directors present, including 6 in person [2] - The board approved a proposal to participate in the auction for a 60% stake in Guotou Agricultural Products Supply Chain (Beijing) Co., Ltd., with a voting result of 6 in favor, 0 against, and 1 abstention [2] - The independent director abstained from voting due to concerns about the fairness of the pricing based on the evaluation results provided by the transferring party [2] Group 2 - The company plans to participate in the auction for a 60% stake in Guotou Agricultural Products, with a starting price of 99.7776 million yuan [8] - The auction is scheduled to be publicly listed from January 26, 2026, to February 28, 2026, and the final transaction price will be determined by the bidding parties [8] - The financial data for Guotou Agricultural Products indicates projected revenues of 585.669 million yuan for 2024, which exceeds 50% of the company's projected revenues for the same year [8] Group 3 - The company aims to enhance its business operations and strategic positioning by acquiring Guotou Agricultural Products, aligning with national policies promoting market-oriented mergers and acquisitions [15] - The acquisition is expected to improve the company's operational capabilities and risk resilience by integrating resources and enhancing business synergies [15] - If successful, the acquisition will allow the company to expand its presence in the agricultural products trade sector, contributing to its goal of becoming a leading operator in urban-rural circulation infrastructure [16] Group 4 - The company will seek shareholder approval for the auction participation, with the authorization valid from the approval date until the conclusion of the auction [17] - The independent directors and the board's strategic committee have reviewed and supported the acquisition proposal, confirming its alignment with the company's strategic development plan [18]

Core Viewpoint - The Shanghai Pudong Construction Co., Ltd. has announced the appointment of Mr. Huang Wei as the new General Manager following the resignation of Mr. Zhao Weicheng from the position, while Mr. Zhao will continue to serve as the Chairman of the Board and in other roles [33][34][36]. Group 1: Board Meeting Resolutions - The board meeting was held from January 29 to February 6, 2026, with all 8 participating directors voting [1][3]. - The board approved the nomination of Mr. Huang Wei as a non-independent director candidate [2]. - The board also approved the appointment of Mr. Huang Wei as the General Manager, effective from the date of the board's approval until the end of the current board's term [4][5]. Group 2: Upcoming Shareholder Meeting - The company will hold its second extraordinary general meeting on March 4, 2026, at 14:45, combining on-site and online voting methods [7][15]. - Voting will be conducted through the Shanghai Stock Exchange's network voting system during specified time slots on the day of the meeting [16][17]. Group 3: Management Changes - Mr. Zhao Weicheng submitted his resignation as General Manager due to work adjustments but will remain as Chairman and in other committee roles [33][34]. - Mr. Huang Wei, previously the Deputy General Manager, has been appointed as General Manager, with his term aligned with the current board's term [36].

Core Viewpoint - The company, Lingyun Industrial Co., Ltd., announced that its controlling shareholder, Northern Lingyun Industrial Group Co., Ltd., plans to issue a non-public exchangeable bond totaling up to 500 million yuan, backed by a portion of its A-share stock holdings [1][2]. Group 1: Bond Issuance Details - The exchangeable bonds will be secured by stocks held by Lingyun Group, which will be managed by CITIC Securities as the trustee [2]. - A total of 50 million shares, representing 4.09% of the company's total issued share capital, will be placed into a trust account for the bond issuance [2][3]. - The bond issuance has received approval from the Shanghai Stock Exchange, confirming that it meets the conditions for listing and transfer [1]. Group 2: Shareholding Structure Post-Issuance - After the completion of the trust registration, Lingyun Group will directly hold 339,980,342 shares, which is 27.82% of the company, while the shares in the trust account will account for 4.09% [3]. - The issuance of the bonds and the trust registration will not change the controlling shareholder or actual controller of the company, nor will it constitute a takeover bid [3]. Group 3: Ongoing Monitoring - The company will continue to monitor the progress of the bond issuance and fulfill its information disclosure obligations to investors [3].

Group 1 - The company, Anhui Liuguo Chemical Co., Ltd., received a government subsidy of RMB 4.5 million, which accounts for 17.87% of the company's audited net profit attributable to shareholders for 2024 [2] - The subsidy is classified as a government grant related to income, according to the relevant provisions of the Accounting Standards for Enterprises [3] - The accounting treatment and impact of the subsidy on the company's financial results for 2026 and subsequent years will be confirmed by the annual audit [3]

证券代码：600688 证券简称：上海石化 公告编号：临2026-005 中国石化上海石油化工股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 中国石化上海石油化工股份有限公司（以下简称"本公司"或"上海石化"）第十一届董事会第二十五次会 议于2026年2月4日召开，董事会决议于2026年3月3日以现场投票表决和网络投票相结合的方式召开本公 司2026年第一次临时股东会，现将本次股东会的有关事项公告如下： 重要内容提示： ● 股东会召开日期：2026年3月3日 ● 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 (二)股东会召集人：本公司董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式，本公司的A股股东 既可参与现场投票，也可以在网络投票时间内通过上海证券交易所股东会网络投票系统参加网络投票。 (四)现场会议召开的日期、时间和地点 召开的日期、时间：2026年3月3日 14 点00分 召开地点：中国上海市金山区金一东路1号金 ...

Core Viewpoint - The company, Shuangliang Energy System Co., Ltd., has announced that its convertible bonds ("Shuangliang Convertible Bonds") are expected to meet the redemption conditions based on stock price performance [1] Group 1: Convertible Bond Redemption Conditions - From January 26, 2026, to February 6, 2026, the company's stock price has closed at or above 130% of the current conversion price of the convertible bonds, which is 6.18 CNY per share, meaning the threshold is 8.03 CNY per share [2][9] - If the stock price remains above this threshold for at least 15 out of 30 consecutive trading days, the company has the right to redeem all or part of the unconverted "Shuangliang Convertible Bonds" at face value plus accrued interest [2][7] Group 2: Convertible Bond Issuance Overview - The company issued 26 million convertible bonds at a face value of 100 CNY each, raising a total of 260 million CNY, with a maturity of 6 years [3] - The bonds were listed on the Shanghai Stock Exchange on September 8, 2023, under the code "110095" [3] Group 3: Conversion Price Adjustments - The initial conversion price was set at 12.13 CNY per share, which was adjusted to 11.93 CNY per share on September 26, 2023, due to a semi-annual dividend distribution [4] - Further adjustments are scheduled, with the conversion price expected to be reduced to 11.81 CNY per share on June 12, 2024, and subsequently to 7.20 CNY per share on October 25, 2024 [5][6]

Core Viewpoint - The company has approved the use of idle raised funds for cash management, allowing for the investment of up to 2.1 billion yuan in low-risk financial products to enhance liquidity and returns [1][2]. Group 1: Cash Management Approval - The company's board approved the use of up to 2.1 billion yuan of temporarily idle raised funds for cash management, focusing on safe and liquid financial products [1]. - The approved financial products include structured deposits, agreed deposits, notice deposits, large certificates of deposit, and income certificates, with a validity period of 12 months from the board's approval [1]. Group 2: Implementation and Returns - The company signed agreements with Industrial Bank and China Merchants Bank for structured deposit products, fully redeeming the cash management funds and recovering the principal of 2.1 billion yuan [2]. - The company earned a total return of 2.7978 million yuan from these cash management activities, with 1.9531 billion yuan used to replace self-raised funds for investment projects and issuance costs [2]. - The company has adhered to the authorized limits and timelines for cash management, with no overdue amounts reported [2].

Core Viewpoint - Hunan Jingfeng Pharmaceutical Co., Ltd. is undergoing a restructuring process, which poses a risk of significant downward adjustment in its stock price due to the implementation of its restructuring plan [2][5][26]. Group 1: Stock Price Adjustment Risks - The company plans to implement a capital reserve conversion to increase its share capital, with a proposed ratio of 10 shares for every 10 shares held, resulting in a total share capital increase from 879,774,351 shares to 1,759,548,702 shares [3][14]. - The adjustment of the stock price reference for the capital reserve conversion will depend on the closing price on the registration date. If the closing price is equal to or below the average price of 2.34 yuan per share, no adjustment will be made; otherwise, the reference price will be adjusted accordingly [4][18]. Group 2: Restructuring Process and Uncertainties - The company has been placed under restructuring by the Changde Intermediate People's Court, which carries the risk of bankruptcy if the restructuring fails. If declared bankrupt, the company will undergo liquidation, and its stock may face delisting [2][5][26]. - The company has reported negative net profits for the years 2022, 2023, and 2024, which raises concerns about its ability to continue as a going concern, as highlighted in the audit report by Da Xin Accounting Firm [5][9]. Group 3: Financial Advisory and Compliance - Zhongde Securities Co., Ltd. has provided a special opinion on the adjustment of the stock price reference calculation formula, stating that the capital reserve conversion is part of the overall restructuring plan and differs from typical capital reserve conversions [25]. - The company is committed to adhering to relevant regulations and will continue to disclose information in accordance with the Shenzhen Stock Exchange's rules and guidelines [27][37].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000590 证券简称：古汉医药 公告编号：2026-004 古汉医药集团股份公司 关于控股子公司重大诉讼的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.案件所处的诉讼阶段：一审法院已立案受理，案号为(2026)京0108民初2924号，案由为买卖合同纠纷 案，本案暂未开庭审理。 2.上市公司下属控股子公司所处的当事人地位：原告。 3.涉案的金额：合同款人民币2,000万元、资金占用损失（含违约责任）；及相关律师费、保全费、保全 担保费、诉讼费等全部费用。 4.对上市公司损益产生的影响：目前该案件尚未判决，公司尚无法判断最终诉讼结果。最终结果对公司 本期利润或期后利润的影响尚存在不确定性。 一、本次重大诉讼受理的基本情况 古汉医药集团股份公司（以下简称"公司"）下属控股子公司湖南启迪药业生物有限公司（以下简称"原 告"、"子公司"）向北京市海淀区人民法院递交民事起诉状，起诉宁波医多多电子商务有限公司退还合 同款，同时诉福州市乐拓企业管理有限公司、北京涂多多电子商务股份有限公 ...

Group 1 - The company will hold its first extraordinary general meeting of shareholders in 2026 on February 25, 2026, at 14:30 [2][3] - The meeting will be conducted in a combination of on-site voting and online voting [4] - Shareholders registered by the cut-off date of February 11, 2026, will have the right to attend the meeting [5][6] Group 2 - The board of directors approved a proposal to apply for financing and provide guarantees, with a total limit not exceeding RMB 600 million [18][34] - The financing will be conducted with various banks, including Guangzhou Bank, Ping An Bank, and China Communications Bank [18][34] - The proposal includes provisions for the company to provide guarantees using its own assets and for its subsidiaries [18][34] Group 3 - The company’s actual controllers will provide joint liability guarantees for the financing without charging guarantee fees [18][26] - The proposal is valid for one year from the date of approval by the extraordinary general meeting [18][26] - The independent directors have unanimously agreed to submit the proposal to the board for approval [27][37] Group 4 - As of the announcement date, the total amount of guarantees provided by the company and its subsidiaries is RMB 422 million, accounting for 55.19% of the company's audited net assets for 2024 [28][46] - The actual amount of guarantees is RMB 359.63 million, which is 47.04% of the company's audited net assets for 2024 [28][46] - The company has no overdue guarantees or guarantees involving litigation [28][46]